32nd Biennial Cornea Conference

第32届双年度角膜会议

• 批准号: 10539749
• 负责人: ILENE K. GIPSON
• 金额: $ 2.5万
• 依托单位: SCHEPENS EYE RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-01 至 2023-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10539749
• 关键词: American; Anterior; Area; Award; Basic Science; Blindness; Boston; Charge; Clinical Research; Collaborations; Cornea; Corneal Diseases; Development; Diagnosis; Disease; Doctor of Philosophy; Ear; Electronic Mail; Endothelium; Environment; Eye; Eye diseases; Face; Faculty; Failure; Feedback; Fostering; Functional disorder; Funding; Goals; Graft Rejection; Immune; Immunologics; Immunology; Keratitis; Laboratory Research; Lead; Massachusetts; Methods; Microbiology; Names; Ophthalmology; Oral; Pathogenesis; Pathologic; Physicians; Quality of life; Regenerative Medicine; Reporting; Research; Research Institute; Research Personnel; Science; Scientist; Senior Scientist; Societies; Surveys; Time; Transplantation; Travel; Universities; Vision; Visual impairment; Work; age group; aging population; design; endothelial dysfunction; eye dryness; graduate student; improved; innovation; insight; lectures; medical schools; meetings; member; microbial; mid-career faculty; multidisciplinary; new technology; next generation; ocular surface; posters; prevent; professor; programs; skills; success; symposium; translational applications; transplantation medicine

Abstract Funds are requested to support trainee participation at the 32nd Biennial Cornea Conference to be held at Schepens Eye Research Institute of Massachusetts Eye and Ear on October 21-22, 2022. The program for the conference was developed by the co-chairs, Dr. Ilene Gipson, PhD, Professor Emeritus at Harvard Medical School, Dr. Ula Jurkunas, MD, Associate Professor of Ophthalmology at Harvard Medical School, Dr. Reza Dana, MD, MPH, Claes H. Dohlman Professor of Ophthalmology at Harvard Medical School, and an organizing committee of eleven experts in the field of Cornea from Harvard, Tufts, and Boston University Medical Schools. The program builds on the success of the previous 31 conferences, first started in the 1960s. Despite advancements in the field, corneal disease and blindness remain common causes of vision loss and impairment worldwide and across all age groups. It is imperative to better understand the mechanisms behind corneal disease development and to develop new methods of diagnosis and treatment. The goals of this conference are to create an opportunity for discussion and for the formation of collaborations aimed at elucidating the mechanisms that underlie the development of various ocular surface and corneal diseases, and to provide trainees in the field an opportunity to present their research and meet leaders in the field. Sessions on the ocular surface, immunologic and microbiologic aspects of corneal disease, as well as discussions on the endothelium and regenerative medicine & transplantation are planned. After receiving positive feedback from the 31st Biennial, an additional panel has been added to the program. Though panelists are still being determined by the committee, panel discussions on areas of greatest unmet need in cornea, controversies in corneal pathobiology, and innovation & new technologies have been planned. A unique feature of this small conference is the ample time allowed for discussion after each speaker presentation, as well as ample time for dedicated poster sessions highlighting trainee research. We anticipate at least 70 poster presentations that will allow trainees the opportunity to present their research to all conference attendees, receive immediate feedback, and engage leading experts in cornea in conversation over their work. As is tradition, the conference honors an accomplished physician scientist and a scientist with the two named lectures. Dr. Stefano Bonini, MD, will give the Claes H. Dohlman Lecture and Dr. Arlene Sharpe MD, PhD, will give the J. Wayne Streilein Lecture. The anticipated attendance for the conference is 250 physicians, scientists, and trainees. We intend to provide travel awards to attract graduate students and fellows and will make every attempt to make the conference free of charge for all trainees.

抽象的 要求资金支持在第32届双年两年期角膜会议上的参与 马萨诸塞州的Schepens Eye研究所眼睛和耳朵于2022年10月21日至22日。 会议由联合主席，伊琳·吉普森（Ilene Gipson）博士，哈佛医疗学院名誉教授 学校，医学博士Ula Jurkunas博士，哈佛医学院眼科副教授，Reza博士 医学博士Dana，MPH，Claes H. Dohlman在哈佛医学院的眼科教授和 哈佛，塔夫茨大学和波士顿大学角膜领域的11个专家的组织委员会 医学院。该计划以前31次会议的成功为基础，该会议于1960年代首次开始。 尽管该领域取得了进步，但角膜疾病和失明仍然是视力丧失和 全世界和所有年龄段的损害。必须更好地了解背后的机制 角膜疾病的发展并开发新的诊断和治疗方法。目标的目标 会议是为讨论和建立针对的合作的机会 阐明各种眼表和角膜疾病发展的机制，以及 为该领域的受训者提供机会展示他们的研究并与该领域的领导人见面。会议 在眼表，角膜疾病的免疫学和微生物学方面，以及关于 计划了内皮和再生医学和移植。收到积极的反馈后 从第31个双年展开始，该计划添加了一个附加的面板。虽然小组成员仍在 由委员会决定，小组讨论角膜中最大未满足需求的领域，争议 已经计划了角膜病理生物学，创新和新技术。这个小的独特功能 会议是每次演讲者演讲后允许讨论的充足时间，以及足够的时间 专门的海报会议突出了学员研究。我们预计至少有70张海报演示文稿 允许学员有机会向所有会议参与者展示他们的研究，立即获得 反馈，并吸引角膜领域的领先专家就其工作进行对话。作为传统，会议 荣誉两位命名讲座的有成就的医师科学家和科学家。 Stefano Bonini博士， 医学博士，将为Claes H. Dohlman演讲和Arlene Sharpe博士博士提供J. Wayne Streilein 演讲。会议的预期出勤是250名医师，科学家和学员。我们打算 提供旅行奖，以吸引研究生和研究员，并将尽一切努力 所有学员免费会议。